BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 7536288)

  • 1. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
    Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
    J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
    Chong P; Zobrist G; Sia C; Loosmore S; Klein M
    Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.
    De Magistris MT; Romano M; Bartoloni A; Rappuoli R; Tagliabue A
    J Exp Med; 1989 May; 169(5):1519-32. PubMed ID: 2469760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA; Raupach B; Szulczynski M; Marzillier J
    Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
    Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
    Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.
    Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA
    Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of B-cell epitopes on the S4 subunit of pertussis toxin.
    Ibsen PH; Holm A; Petersen JW; Olsen CE; Heron I
    Infect Immun; 1993 Jun; 61(6):2408-18. PubMed ID: 7684728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.
    Kim KJ; Burnette WN; Sublett RD; Manclark CR; Kenimer JG
    Infect Immun; 1989 Mar; 57(3):944-50. PubMed ID: 2465274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin.
    Schmidt W; Schmidt MA
    Infect Immun; 1989 Feb; 57(2):438-45. PubMed ID: 2463969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of T cell epitopes on the S1 subunit of pertussis toxin.
    Kim KJ; McKinness S; Manclark CR
    J Immunol; 1990 May; 144(9):3529-34. PubMed ID: 1691761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.
    Leininger E; Bowen S; Renauld-Mongénie G; Rouse JH; Menozzi FD; Locht C; Heron I; Brennan MJ
    J Infect Dis; 1997 Jun; 175(6):1423-31. PubMed ID: 9180182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
    Motté P; Alberici G; Ait-Abdellah M; Bellet D
    J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin.
    Léonetti M; Pillet L; Maillère B; Lamthanh H; Frachon P; Couderc J; Ménez A
    J Immunol; 1990 Dec; 145(12):4214-21. PubMed ID: 1701784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.